The antibiotic puromycin attaches covalently to the C terminus of nascent polypeptide chains, causing their premature termination and rapid dissociation from ribosomes. This mechanism allows the use of puromycin to assay protein synthesis in cells by detection of polypeptide-puromycin conjugates with tritiated puromycin (1), antipuromycin antibodies (2), or clickable Opropargyl-puromycin (3). Although antipuromycin antibodies work well on blots and for FACS analysis (2), they reveal a subcellular pattern of puromycin conjugates that is significantly different from the pattern of the methionine analog homopropargylglycine (4), O-propargyl-puromycin (3), and tritiated puromycin (1) (see below).
The letter by Goodman et al. (5) figure S3 A and C), in which the puromycin signal seemed concentrated at the membrane and excluded from the nucleus. This pattern was inconsistent with what we knew from other methods about the identity and the subcellular distribution of newly synthesized proteins. First, mass spectrometric identification of newly synthesized proteins labeled with the methionine analog azidohomoalanine indicated that nuclear and nucleolar proteins were among the most abundant newly synthesized proteins in cultured cells. Second, a clear nuclear signal was seen when newly synthesized proteins were labeled with three totally different tracers: homopropargylglycine (4), O-propargyl-puromycin (3), and radioactive puromycin (1). In the case of O-propargyl-puromycin and radioactive puromycin, this nuclear signal suggested that some puromycin conjugates localized to the nucleus after their release from ribosomes. Although we did not know why antipuromycin immunofluorescence did not detect nuclear puromycin conjugates, we speculated that some of the conjugates were inaccessible to antipuromycin antibodies but were readily accessible to the small-molecule fluorescent azides used to detect O-propargyl-puromycin (3).
We do not agree with the letter by Goodman et al. (5) that puromycin conjugates should colocalize with ribosomes. Once formed on the ribosome, a puromycin conjugate dissociates from it and is free to diffuse rapidly, just like a completed polypeptide chain. The letter by Goodman et al. (5) cites the work by David et al. (6) as evidence that polypeptide-puromycin conjugates colocalize with ribosomes on the endoplasmic reticulum. This reading of the work by David et al. (6) ignores the critical fact that the experiment was performed in the presence of cycloheximide (6) , which blocks the dissociation of polypeptide-puromycin conjugates from ribosomes. Furthermore, the work by David et al. (6) used a permeabilization step before fixation to remove soluble polypeptide-puromycin conjugates (6) . Thus, the staining pattern observed in the work by David et al. (6) was the pattern of puromycin conjugates that are prevented from leaving the ribosome, which is very different from the studies that used puromycin without cycloheximide (2, 3); thus, this finding cannot be taken to reflect the normal distribution of puromycin conjugates in a cell. 
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